urtoxazumab
visilizumab
sifalimumab
furazolidone
vedolizumab
tefibazumab
suvratoxumab
efungumab
liposidomycin
polyvalent
etesevimab
bacterioagglutinin
coproantibody
immunobiotic
-bac-
colibacillus
bacterize
brazikumab
Salmonella enteritidis
ixekizumab
lintuzumab
giardia
matuzumab
pexiganan
cantuzumab
certolizumab
colibacillosis
Gartner's bacillus
ocrelizumab
microbiome
coliphage
lasalocid
abrilumab
clofoctol
nebacumab
-les-
bacterioscopical
lacticin
heterophile antibody
beta-lactamase
intetumumab
Forssman antibody
New Delhi metallo-beta-lactamase-1
glembatumumab
heterophil antibody
inotuzumab ozogamicin
stomach flu
elotuzumab
diastomyelia
actoxumab
fontolizumab
enterophage
bacteraemia
dysentery
sonepcizumab
dacetuzumab
tucotuzumab
synechococcal
evolocumab
caplacizumab
bacteriotherapeutic
onartuzumab
coccic
IgG
colibacilluria
immunoglobulin G
labetuzumab
ruplizumab
rovelizumab
balsalazide
bivatuzumab
vaccinate
cefsumide
ozogamicin
meropenem
tisotumab
craps
sanfetrinem
-zumab
oximonam
gastro
inflammatory bowel disease
pirazmonam
brobactam
ozoralizumab
bacmecillinam
sulopenem
sibrotuzumab
amlitelimab
tomopenem
flucloxacillin
cestodiasis
MacConkey agar
bactericidin
lactococcin
vobarilizumab
verbal diarrhea
immune
bacterio-